INS and type 2 diabetes mellitus: Here, we report for the first time, to our knowledge, the potential to improve insulin secretion in the INS-1 rat insulin-secreting β-cell line using isoflavonoids isolated from A. membranaceus, evaluated as a treatment strategy for T2D.